AAAAAA
Results: 1-25/31
Authors:
Eisenbud, R
Assmann, SF
Kalish, LA
van der Horst, C
Collier, AC
Citation: R. Eisenbud et al., Differences difficulty adjudicating clinical events in patients with advanced HIV disease, J ACQ IMM D, 28(1), 2001, pp. 43-46
Authors:
Para, MF
Kalish, LA
Collier, AC
Pollard, RB
Kumar, PN
Mintz, L
Wallach, FR
Drew, WL
Citation: Mf. Para et al., Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions, J ACQ IMM D, 26(4), 2001, pp. 320-325
Authors:
Murphy, EL
Assmann, SF
Collier, AC
Flanigan, TP
Kumar, PN
Wallach, FR
Krubel, S
Citation: El. Murphy et al., Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998, CLIN INF D, 32(1), 2001, pp. 116-123
Authors:
Arduino, JM
Fischl, MA
Stanley, K
Collier, AC
Spiegelman, D
Citation: Jm. Arduino et al., Do HIV type 1 RNA levels provide additional prognostic value to CD4(+) T lymphocyte counts in patients with advanced HIV type 1 infection?, AIDS RES H, 17(12), 2001, pp. 1099-1105
Authors:
Havlir, DV
Gilbert, PB
Bennett, K
Collier, AC
Hirsch, MS
Tebas, P
Adams, EM
Wheat, LJ
Goodwin, D
Schnittman, S
Holohan, MK
Richman, DD
Citation: Dv. Havlir et al., Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression, AIDS, 15(11), 2001, pp. 1379-1388
Authors:
Havlir, DV
Bassett, R
Levitan, D
Gilbert, P
Tebas, P
Collier, AC
Hirsch, MS
Ignacio, C
Condra, J
Gunthard, HF
Richman, DD
Wong, JK
Citation: Dv. Havlir et al., Prevalence and predictive value of intermittent viremia with combination HIV therapy, J AM MED A, 286(2), 2001, pp. 171-179
Authors:
Collier, AC
Kalish, LA
Busch, MP
Gernsheimer, T
Assmann, SF
Lane, TA
Asmuth, DM
Lederman, MM
Murphy, EL
Kumar, P
Kelley, M
Flanigan, TP
McMahon, DK
Sacks, HS
Kennedy, MS
Holland, PV
Citation: Ac. Collier et al., Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection - The viral activation transfusion study: A randomized controlled trial, J AM MED A, 285(12), 2001, pp. 1592-1601
Authors:
Seth, A
Markee, J
Hoering, A
Sevin, A
Sabath, DE
Schmitz, RE
Kuroda, MJ
Lifton, MA
Hirsch, MS
Collier, AC
Letvin, NL
McElrath, J
Citation: A. Seth et al., Alterations in T cell phenotype and human immunodeficiency virus type 1 - Specific cytotoxicity after potent antiretroviral therapy, J INFEC DIS, 183(5), 2001, pp. 722-729
Authors:
Para, MF
Kalish, LA
Collier, AC
Murphy, EL
Drew, WL
Citation: Mf. Para et al., Correlates of change in cytomegalovirus viremia in patients with advanced human immunodeficiency virus infection who require transfusion, J INFEC DIS, 183(11), 2001, pp. 1673-1677
Authors:
Berrey, MM
Schacker, T
Collier, AC
Shea, T
Brodie, SJ
Mayers, D
Coombs, R
Krieger, J
Chun, TW
Fauci, A
Self, SG
Corey, L
Citation: Mm. Berrey et al., Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS, J INFEC DIS, 183(10), 2001, pp. 1466-1475
Authors:
Curtis, JR
Patrick, DL
Caldwell, ES
Collier, AC
Citation: Jr. Curtis et al., Abuse of futility - Reply, ARCH IN MED, 161(1), 2001, pp. 129-130
Authors:
Murphy, EL
Collier, AC
Kalish, LA
Assmann, SF
Para, MF
Flanigan, TP
Kumar, PN
Mintz, L
Wallach, FR
Nemo, GJ
Citation: El. Murphy et al., Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease, ANN INT MED, 135(1), 2001, pp. 17-26
Authors:
Boutin, PD
Buchwald, D
Robinson, L
Collier, AC
Citation: Pd. Boutin et al., Use of and attitudes about alternative and complementary therapies among outpatients and physicians at a municipal hospital, J ALTERN C, 6(4), 2000, pp. 335-343
Authors:
Vanhems, P
Hughes, J
Collier, AC
Vizzard, J
Perrin, L
Cooper, DA
Hirschel, B
Corey, L
Citation: P. Vanhems et al., Comparison of clinical features, CD4 and CD8 responses among patients withacute HIV-1 infection from Geneva, Seattle and Sydney, AIDS, 14(4), 2000, pp. 375-381
Authors:
Zhou, XJ
Havlir, DV
Richman, DD
Acosta, EP
Hirsch, M
Collier, AC
Tebas, P
Sommadossi, JP
Citation: Xj. Zhou et al., Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients, AIDS, 14(18), 2000, pp. 2869-2876
Authors:
Haas, DW
Arathoon, E
Thompson, MA
Pedro, RD
Gallant, JE
Uip, DE
Currier, J
Noriega, LM
Lewi, DS
Uribe, P
Benetucci, J
Cahn, P
Paar, D
White, CA
Collier, AC
Ramirez-Ronda, CH
Harvey, C
Chung, M
Mehrotra, D
Chodakewitz, J
Nguyen, BY
Citation: Dw. Haas et al., Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine, AIDS, 14(13), 2000, pp. 1973-1978
Authors:
Ioannidis, JPA
Havlir, DV
Tebas, P
Hirsch, MS
Collier, AC
Richman, DD
Citation: Jpa. Ioannidis et al., Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication, AIDS, 14(11), 2000, pp. 1481-1488
Authors:
Havlir, DV
Hellmann, NS
Petropoulos, CJ
Whitcomb, JM
Collier, AC
Hirsch, MS
Tebas, P
Sommadossi, JP
Richman, DD
Citation: Dv. Havlir et al., Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens, J AM MED A, 283(2), 2000, pp. 229-234
Authors:
Collier, AC
Tingle, MD
Keelan, JA
Paxton, JW
Mitchell, MD
Citation: Ac. Collier et al., A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines, DRUG META D, 28(10), 2000, pp. 1184-1186
Authors:
Para, MF
Glidden, DV
Coombs, RW
Collier, AC
Condra, JH
Craig, C
Bassett, R
Leavitt, R
Snyder, S
McAuliffe, V
Boucher, C
Citation: Mf. Para et al., Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS Clinical Trials Group protocol 333, J INFEC DIS, 182(3), 2000, pp. 733-743
Authors:
Kalish, LA
Collier, AC
Flanigan, TP
Kumar, PN
Citation: La. Kalish et al., Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and womenwith advanced HIV-1 disease, J INFEC DIS, 182(2), 2000, pp. 603-606
Authors:
Curtis, JR
Patrick, DL
Caldwell, ES
Collier, AC
Citation: Jr. Curtis et al., The attitudes of patients with advanced AIDS toward use of the medical futility rationale in decisions to forgo mechanical ventilation, ARCH IN MED, 160(11), 2000, pp. 1597-1601
Authors:
Curtis, JR
Patrick, DL
Caldwell, ES
Collier, AC
Citation: Jr. Curtis et al., Why don't patients and physicians talk about end-of-life care? Barriers tocommunication for patients with acquired immunodeficiency syndrome and their primary care clinicians, ARCH IN MED, 160(11), 2000, pp. 1690-1696
Authors:
Revicki, DA
Swartz, C
Wu, AW
Haubrich, R
Collier, AC
Citation: Da. Revicki et al., Quality of life outcomes of saquinavir, zalcitabine and combination saquinavir plus zalcitabine therapy for adults with advanced HIV infection with CD4 counts between 50 and 300 cells/mm(3), ANTIVIR TH, 4(1), 1999, pp. 35-44
Authors:
Curtis, JR
Patrick, DL
Caldwell, E
Greenlee, H
Collier, AC
Citation: Jr. Curtis et al., The quality of patient-doctor communication about end-of-life care: a study of patients with advanced AIDS and their primary care clinicians, AIDS, 13(9), 1999, pp. 1123-1131